一圖看懂聯合醫務(00722.HK)2020年中期業績
來源:格隆匯•匯圖

聯合醫務集團有限公司(UMP)成立於1990年,是大中華區前列的企業醫療保健解決方案提供者之一。30年來一直致力於讓所有人獲得可信任及可負擔的服務,從而在不用擔憂健康的考慮下,追求自己的夢想。聯合醫務與企業和保險公司合作,為其員工及會員設計和管理企業醫療保健福利計劃,併為其提供醫療保健服務。
近年來,聯合醫務更緊貼國家政策,在國內主要城市發展家庭醫生培訓服務,並與當地小區衞生服務中心一起打造公私合營的聯合醫務工作室。2020年度,聯合醫務服務超過3,000家企業和保險公司,醫生與服務夥伴逾700名,累積逾100萬會員,年就診人次超過160萬。
報告期內,公司營業收入錄得3.07億港元,同比增長17.2%;經調整後EBITDA為5030.7萬港元,同比增長28.5%,利潤率為16.4%;中期股息為0.65港仙。公司更多業績亮點如下:

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.